Annemieke M. Boot

5.2k total citations · 1 hit paper
88 papers, 3.8k citations indexed

About

Annemieke M. Boot is a scholar working on Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Orthopedics and Sports Medicine. According to data from OpenAlex, Annemieke M. Boot has authored 88 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Pediatrics, Perinatology and Child Health and 19 papers in Orthopedics and Sports Medicine. Recurrent topics in Annemieke M. Boot's work include Bone health and osteoporosis research (16 papers), Growth Hormone and Insulin-like Growth Factors (14 papers) and Childhood Cancer Survivors' Quality of Life (13 papers). Annemieke M. Boot is often cited by papers focused on Bone health and osteoporosis research (16 papers), Growth Hormone and Insulin-like Growth Factors (14 papers) and Childhood Cancer Survivors' Quality of Life (13 papers). Annemieke M. Boot collaborates with scholars based in Netherlands, United States and United Kingdom. Annemieke M. Boot's co-authors include Sabine M.P.F. de Muinck Keizer‐Schrama, Eric P. Krenning, Huibert A. P. Pols, Maria de Ridder, Inge M. van der Sluis, J. Bouquet, E. P. Krenning, Stenvert L. S. Drop, Jan K. Buitelaar and Geert J. M. Boerma and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Annemieke M. Boot

87 papers receiving 3.7k citations

Hit Papers

Burosumab Therapy in Chil... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Burosumab Therapy in Children with X-Linked Hypophosphatemia
    2018 321 citations Thomas O. Carpenter, Michael P. Whyte et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annemieke M. Boot Netherlands 33 922 896 874 869 715 88 3.8k
Wolfgang Högler United Kingdom 42 1.2k 1.3× 513 0.6× 1.1k 1.2× 1.2k 1.4× 468 0.7× 167 4.8k
Karen K. Winer United States 30 978 1.1× 305 0.3× 786 0.9× 723 0.8× 697 1.0× 63 3.7k
Johan Verhaeghe Belgium 39 478 0.5× 1.3k 1.4× 563 0.6× 855 1.0× 373 0.5× 138 4.4k
Giampiero I. Baroncelli Italy 29 675 0.7× 265 0.3× 651 0.7× 626 0.7× 356 0.5× 90 2.5k
Rajata Rajatanavin Thailand 30 1.1k 1.2× 271 0.3× 408 0.5× 955 1.1× 410 0.6× 115 3.1k
Kerstin Landin‐Wilhelmsen Sweden 42 477 0.5× 386 0.4× 1.4k 1.6× 2.0k 2.3× 857 1.2× 127 5.8k
Kristin Godang Norway 34 388 0.4× 701 0.8× 211 0.2× 649 0.7× 370 0.5× 122 3.4k
Joe C. Christian United States 30 1.7k 1.8× 402 0.4× 772 0.9× 597 0.7× 669 0.9× 73 4.1k
Sabine M.P.F. de Muinck Keizer‐Schrama Netherlands 48 753 0.8× 2.5k 2.7× 1.6k 1.8× 2.8k 3.2× 573 0.8× 125 6.9k
Nick J. Shaw United Kingdom 26 353 0.4× 236 0.3× 538 0.6× 354 0.4× 351 0.5× 44 2.1k

Countries citing papers authored by Annemieke M. Boot

Since Specialization
Citations

This map shows the geographic impact of Annemieke M. Boot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annemieke M. Boot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annemieke M. Boot more than expected).

Fields of papers citing papers by Annemieke M. Boot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annemieke M. Boot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annemieke M. Boot. The network helps show where Annemieke M. Boot may publish in the future.

Co-authorship network of co-authors of Annemieke M. Boot

This figure shows the co-authorship network connecting the top 25 collaborators of Annemieke M. Boot. A scholar is included among the top collaborators of Annemieke M. Boot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annemieke M. Boot. Annemieke M. Boot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Renes, Judith S., Ardine Reedijk, Anita Hokken-Koelega, et al.. (2025). Clinical Characteristics and Response to Growth Hormone Treatment in 27 Children With Heterozygous NPR2 Variants: Real-World Data. The Journal of Clinical Endocrinology & Metabolism. 111(1). e166–e174. 1 indexed citations
2.
Saraff, Vrinda, Annemieke M. Boot, Agnès Linglart, et al.. (2024). A patient-centred and multi-stakeholder co-designed observational prospective study protocol: Example of the adolescent experience of treatment for X-linked hypophosphataemia (XLH). PLoS ONE. 19(1). e0295080–e0295080. 1 indexed citations
3.
Appelman‐Dijkstra, Natasha M., Annemieke M. Boot, Martin H. de Borst, et al.. (2024). Disease Manifestations and Complications in Dutch X-Linked Hypophosphatemia Patients. Calcified Tissue International. 114(3). 255–266. 3 indexed citations
4.
Meeteren, Antoinette Y. N. Schouten‐van, Laura van Iersel, Sarah Clement, et al.. (2021). Prevalence and risk factors of hypothalamic–pituitary dysfunction in infant and toddler childhood brain tumor survivors. European Journal of Endocrinology. 185(4). 597–606. 7 indexed citations
5.
Tacke, Carline E., Suzanne W. J. Terheggen-Lagro, Annemieke M. Boot, et al.. (2021). Chondrodysplasia, enchondromas and a chest deformity causing severe pulmonary morbidity in a boy with a PTHLH duplication: A case report. Bone Reports. 14. 101067–101067. 1 indexed citations
6.
Linglart, Agnès, Erik A. Imel, Michael P. Whyte, et al.. (2021). Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia. The Journal of Clinical Endocrinology & Metabolism. 107(3). 813–824. 53 indexed citations
7.
Kalaitzoglou, Evangelia, Edna Majaliwa, Margaret Zacharin, et al.. (2020). Multilingual Global E-Learning Pediatric Endocrinology and Diabetes Curriculum for Front Line Health Care Providers in Resource-Limited Countries: Development Study. JMIR Formative Research. 4(11). e18555–e18555. 6 indexed citations
8.
Padidela, Raja, Ola Nilsson, Outi Mäkitie, et al.. (2020). The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study. Orphanet Journal of Rare Diseases. 15(1). 172–172. 27 indexed citations
9.
Hulst, Annelienke M. van, Sebastian Neggers, Annemieke M. Boot, et al.. (2020). Frailty in long‐term Dutch adult survivors of childhood acute myeloid leukaemia, neuroblastoma, and Wilms' tumour. SHILAP Revista de lepidopterología. 6(1). 3–10. 2 indexed citations
10.
Meeteren, Antoinette Y. N. Schouten‐van, Martijn J.J. Finken, Wilma Oostdijk, et al.. (2018). Management and consequences of postoperative fluctuations in plasma sodium concentration after pediatric brain tumor surgery in the sellar region: a national cohort analysis. Pituitary. 21(4). 384–392. 13 indexed citations
11.
Clement, Sarah, Antoinette Y. N. Schouten‐van Meeteren, Annemieke M. Boot, et al.. (2016). Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter Study. Journal of Clinical Oncology. 34(36). 4362–4370. 65 indexed citations
12.
Bongers, Bart C., et al.. (2015). Efficacy and Safety of Bisphosphonate Therapy in Children with Osteogenesis Imperfecta: A Systematic Review. Hormone Research in Paediatrics. 84(1). 26–42. 50 indexed citations
13.
Liu, Fan, Emile Hendriks, Arwin Ralf, et al.. (2013). Common DNA variants predict tall stature in Europeans. Human Genetics. 133(5). 587–597. 39 indexed citations
14.
Buitelaar, Jan K., et al.. (2012). Risk of Hyperprolactinemia and Sexual Side Effects in Males 10–20 Years Old Diagnosed with Autism Spectrum Disorders or Disruptive Behavior Disorder and Treated with Risperidone. Journal of Child and Adolescent Psychopharmacology. 22(6). 432–439. 36 indexed citations
15.
Hendriks, Emile, Milton R. Brown, Annemieke M. Boot, et al.. (2011). Common polymorphisms in the GH/IGF-1 axis contribute to growth in extremely tall subjects. Growth Hormone & IGF Research. 21(6). 318–324. 8 indexed citations
16.
Boot, Annemieke M., Serge Lumbroso, Miriam Verhoef‐Post, et al.. (2011). Mutation Analysis of the LH Receptor Gene in Leydig Cell Adenoma and Hyperplasia and Functional and Biochemical Studies of Activating Mutations of the LH Receptor Gene. The Journal of Clinical Endocrinology & Metabolism. 96(7). E1197–E1205. 40 indexed citations
17.
Hendriks, Emile, Joop S.E. Laven, Olivier Valkenburg, et al.. (2011). Fertility and Ovarian Function in High-Dose Estrogen-Treated Tall Women. The Journal of Clinical Endocrinology & Metabolism. 96(4). 1098–1105. 29 indexed citations
18.
Hendriks, Emile, Willem P. A. Boellaard, Niels J. van Casteren, et al.. (2010). Fatherhood in Tall Men Treated with High-Dose Sex Steroids during Adolescence. The Journal of Clinical Endocrinology & Metabolism. 95(12). 5233–5240. 22 indexed citations
19.
Harten, Peter N. van, et al.. (2009). Antipsychotic Medication in Children and Adolescents: A Descriptive Review of the Effects on Prolactin Level and Associated Side Effects. Journal of Child and Adolescent Psychopharmacology. 19(4). 403–414. 79 indexed citations
20.
Boot, Annemieke M., J. Bouquet, E. P. Krenning, & Sabine M.P.F. de Muinck Keizer‐Schrama. (1998). Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut. 42(2). 188–194. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wolfgang Högler Breakdown of academic impact, for papers by Karen K. Winer Breakdown of academic impact, for papers by Johan Verhaeghe Breakdown of academic impact, for papers by Giampiero I. Baroncelli Breakdown of academic impact, for papers by Rajata Rajatanavin Breakdown of academic impact, for papers by Kerstin Landin‐Wilhelmsen Breakdown of academic impact, for papers by Kristin Godang Breakdown of academic impact, for papers by Joe C. Christian Breakdown of academic impact, for papers by Sabine M.P.F. de Muinck Keizer‐Schrama Breakdown of academic impact, for papers by Nick J. Shaw
Rankless by CCL
2026